Efficacy of gabapentin as adjunctive therapy in a large, multicenter study

  title={Efficacy of gabapentin as adjunctive therapy in a large, multicenter study},
  author={Martha J. Morrell and Monica J McLean and Luther James Willmore and Michael D. Privitera and Raymond E Faught and Gregory L. Holmes and Leslie Magnus and Paula Bernstein and A. Rose-Legatt and STEPS Study Group},
The objective of this study was to determine the efficacy of gabapentin as adjunctive therapy in doses required to achieve the most effective seizure control. There were 2016 patients with partial seizures requiring adjunctive therapy who received gabapentin at doses up to 3600 mg/day in this open-label, multicenter, 16-week study. Of the 1055 patients evaluable for efficacy, 573 received gabapentin < or =1800 mg/day and 482 received > 1800 mg/day as the highest dose received. For the overall… CONTINUE READING


Publications citing this paper.
Showing 1-9 of 9 extracted citations

New antiepileptic drugs--an overview.

Roczniki Akademii Medycznej w Bialymstoku • 2005


Publications referenced by this paper.
Showing 1-10 of 15 references

Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United States with three novel drugs

J. A. French
Epilepsia • 1996

New antiepileptic drugs.

Bailliere's clinical neurology • 1996
View 1 Excerpt

Similar Papers

Loading similar papers…